Ann: GenScript Further Pre-Clinical Validation for Phase II Trial, page-20

Mattoe,

If my comments have really caused you all this stress then I am sorry, but i would suspect that these comments were said tongue in cheek.

If not then I suggest you dont read my posts, but if anyone one here trade based on what I or others say on HC i would be very very surprised and I suggest they do their own research.

At the end of the day the sp is where it is due to shareholders are either getting out as they see currently there are better money making opportunities elsewhere. The blame imo can be traced back to only one source and that is the failure of current management to deliver what they have claimed they were going to deliver.

The unnecessary delay imo of the canine trials, the added cost of having others on board to market the company and again imo the need for a cr within the next four months

As one other and myself on here posted that the only thing that would come out of a consolidation was lower sp which has happened


DYOR